Basic Super P-Force Information

• INN (International Nonproprietary Name): Sildenafil (PDE5 inhibitor); Dapoxetine (Selective Serotonin Reuptake Inhibitor, SSRI).
• Brand Names Available In Australia: not specified.
• ATC Code: Sildenafil G04BE03; dapoxetine not officially assigned but often listed under N06BX21 in some databases.
• Forms & Dosages: Tablet 100 mg / 60 mg containing sildenafil 100 mg + dapoxetine 60 mg, oral.
• Manufacturers In Australia: not specified.
• Registration Status In Australia: not specified.
• OTC / Rx Classification: Prescription-only (Rx).

Major 2022–2025 Australian & Global Studies

Patients and clinicians ask whether a single tablet that combines erection support and ejaculation delay actually works better than treating each condition separately.

High‑quality randomised controlled trials (RCTs) and meta‑analyses remain the strongest evidence for sildenafil alone in erectile dysfunction and for dapoxetine alone in premature ejaculation.

Since 2022, systematic reviews have reaffirmed the efficacy and tolerability of sildenafil for ED and dapoxetine for PE as monotherapy.

Peer‑reviewed RCT data specifically assessing fixed‑dose combination tablets such as sildenafil 100 mg + dapoxetine 60 mg (often sold as Super P‑Force) are sparse in Australian or EMA/FDA registries.

Real‑world observational series published between 2022 and 2025 from markets where combination products circulate suggest pragmatic benefit for men with coexisting ED and PE.

Those observational reports describe improved intercourse latency and erection hardness compared with baseline and higher patient‑reported satisfaction in mixed cohorts.

However, selection and reporting bias limit how confidently those data can be applied to Australian practice.

Clinicians should interpret Super P‑Force evidence alongside established sildenafil dapoxetine trials for individual agents and maintain realistic expectations about combination safety data.

Main Outcomes

Most observational series report longer intravaginal ejaculatory latency time and better erection hardness when both mechanisms are targeted together.

Patient satisfaction scores rose in mixed cohorts compared with prior monotherapy use or baseline symptoms.

Safety Observations (TGA Reports)

The Therapeutic Goods Administration has not approved the fixed combination in Australia, and TGA pharmacovigilance themes mirror known risks of the component drugs.

Reported safety signals align with hypotension when nitrates are involved, serotoninergic effects from dapoxetine, and the small risk of priapism associated with PDE5 inhibitors.

Layman’s Explanation

Sildenafil helps men get and keep erections by relaxing blood vessels in the penis so more blood can flow in during sexual arousal.

Dapoxetine helps delay ejaculation by changing serotonin signalling in the brain for a short time after a dose.

When taken together in a single tablet, the aim is to address two common problems at once — weak erections and ejaculating sooner than desired.

That combined approach may suit men who have both erectile dysfunction and premature ejaculation at the same time.

Scientific Breakdown

Sildenafil works by inhibiting phosphodiesterase type‑5 (PDE5), which increases cyclic GMP and causes smooth muscle relaxation in the corpus cavernosum.

Increased cGMP improves penile blood inflow and helps achieve firmer erections when sexually stimulated.

Dapoxetine is a short‑acting selective serotonin reuptake inhibitor (SSRI) that raises synaptic serotonin and delays ejaculation via 5‑HT receptor modulation.

Pharmacokinetics & Timing

Sildenafil typically peaks in plasma around 60 minutes after oral dosing but can be affected by food.

Dapoxetine peaks later, usually between one and three hours after a dose.

For a combined single tablet of sildenafil 100 mg + dapoxetine 60 mg, the usual pragmatic timing is one to three hours before intercourse to align both agents’ action windows.

Interaction Potential (Mechanistic)

Combined haemodynamic effects from sildenafil plus vasodilatory influences increase the potential for blood pressure falls when taken with nitrates or some alpha‑blockers.

Dapoxetine’s serotonin‑modulating action raises theoretical and reported risks of serotonin syndrome when combined with other SSRIs, MAO inhibitors or strong serotonergic drugs.

These mechanistic interactions explain why medication reconciliation and cardiovascular assessment are essential before considering combination therapy.

Australian Approvals (TGA‑Listed, PBS Inclusion)

The TGA lists sildenafil and dapoxetine as individual prescription medicines for erectile dysfunction and premature ejaculation respectively.

The fixed‑dose combination tablet (sildenafil 100 mg + dapoxetine 60 mg) is not TGA‑approved as a combined product and is not PBS‑subsidised.

Patients should expect that any combination use will be prescription‑only and that the combination tablet does not have a PBS listing.

Individual agents may have PBS pathways for qualifying indications depending on clinical criteria and concession status.

Notable Off‑Label Trends In Australian Practice

Some clinicians co‑prescribe separate sildenafil and dapoxetine tablets off‑label for men with both ED and PE after specialist review and cardiovascular assessment.

Patients also obtain imported combination tablets through online suppliers, but these carry regulatory and safety uncertainties.

Use of imported combination products bypasses local approval processes and can complicate pharmacovigilance and supply transparency.

Clinical Indications

The combination is intended for adult males, generally aged 18–65, with concomitant erectile dysfunction and premature ejaculation.

Contraindications include concurrent nitrate use, recent myocardial infarction or stroke, unstable angina, severe hepatic impairment, and a history of bipolar disorder or mania.

General Dosing

Combination tablets such as those sold as Super P‑Force typically contain sildenafil 100 mg and dapoxetine 60 mg in one pill and are taken as a single dose one to three hours before sexual activity.

Do not exceed one tablet in any 24‑hour period.

Because the tablet fixes both active doses, it reduces the ability to titrate either agent separately.

Condition‑Specific Dosing (PBS Recommendations)

The PBS does not list the fixed combination, and any PBS guidance applies to individual agents rather than the combo tablet.

Clinical practice often starts older patients or those with comorbidities on lower sildenafil doses (25–50 mg) and dapoxetine on 30 mg with later uptitration to 60 mg if tolerated.

Fixed 100/60 mg tablets limit that flexibility and may not suit men who need dose adjustments for safety or tolerability reasons.

Special Populations

Elderly patients require increased caution and often cardiology review before starting sildenafil at higher strengths.

Hepatic or renal impairment commonly warrants dose reduction or avoidance because of prolonged exposure and higher side‑effect risk.

Children and adolescents are not indicated for these medicines.

Contraindications (Australian Guidelines)

Absolute contraindications include concomitant nitrates, hypersensitivity to sildenafil or dapoxetine, recent myocardial infarction or stroke, unstable angina, severe hepatic impairment and a history of mania or bipolar disorder.

Exercise caution with alpha‑blockers, certain antihypertensives and in poorly controlled cardiovascular disease.

Adverse Effects (Post‑Market Pharmacovigilance)

Common side effects reported with the combination reflect the component profiles and include headache, flushing, dyspepsia, nasal congestion, dizziness and nausea.

Dapoxetine adds insomnia, restlessness and other serotonin‑related effects to the expected side‑effect mix.

Serious but rare events include priapism, marked hypotension and serotonin syndrome when other serotonergic drugs are present.

The TGA advises clinicians and patients to report adverse events from imported combination products to support safety monitoring.

Clinical Monitoring

Start with a pre‑treatment cardiovascular assessment and medication reconciliation to identify nitrates, SSRIs or other interacting drugs.

Counsel patients to seek urgent care for erections lasting longer than four hours or for sudden severe dizziness or fainting.

Document counselling, advise follow‑up and report any suspected adverse reactions to the TGA.

Food Interactions (Alcohol, Coffee, Diet In Australia)

Alcohol in excess amplifies orthostatic hypotension and impairs judgement during sexual activity when combined with sildenafil and dapoxetine.

Caffeine has minimal direct pharmacokinetic interaction but can worsen anxiety and insomnia, which dapoxetine may also provoke.

High‑fat meals can delay sildenafil absorption and may push peak effect later in the one‑to‑three‑hour window.

Advise taking the tablet one to three hours before intercourse and avoid heavy alcohol intake on dosing nights.

Drug Combinations To Avoid (TGA Safety Alerts)

Never combine sildenafil with nitrates or nitric oxide donors because of the risk of dangerous hypotension.

Use caution with alpha‑blockers because combined vasodilatory effects can cause clinically significant blood pressure drops.

Potent CYP3A4 inhibitors such as ritonavir or ketoconazole may increase sildenafil exposure and risk of adverse effects.

Strong CYP2D6 inhibitors can affect dapoxetine metabolism and raise serotoninergic risk, and concurrent SSRIs or MAO inhibitors increase the chance of serotonin syndrome.

Australian Survey Data

Formal Australian surveys focused on fixed‑dose sildenafil+dapoxetine combinations are limited in the public literature.

Local sexual health clinics report patient demand for dual‑action treatments, especially when both conditions coexist.

When clinicians prescribe sildenafil and dapoxetine separately with oversight, patient satisfaction often improves for dual‑diagnosis cases.

Access and affordability are common barriers, especially outside metropolitan areas.

Forum And Pharmacy Trends

Online forums and e‑pharmacies show strong interest in Super P‑Force and higher‑strength Extra Super P‑Force variants.

Community pharmacists report frequent enquiries about imported combination tablets and commonly advise caution about supply quality.

Rural patients often use telehealth scripts and online ordering to overcome limited local specialist access, which raises the risk of unregulated supply.

Counselling Needs

Patients typically worry about cost, legality of import, and what side effects to expect, and they ask whether the combo is safe with other drugs.

Pharmacists are well placed to triage risk, check interactions, counsel on side‑effect recognition and refer to prescribers when needed.

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Major Australian retail chains stock PBS‑listed generics for sildenafil monotherapy but do not sell unapproved fixed‑dose combinations like Super P‑Force.

When asked, pharmacists at Chemist Warehouse, Priceline and TerryWhite generally refer customers back to their prescriber and warn about online imports.

Online Pharmacy Growth And Telehealth E‑Scripts

Telehealth consultations and e‑scripts have expanded access to treatments for ED and PE in Australia.

However, many online pharmacies based offshore supply Super P‑Force and similar combination products, and these sources are outside TGA oversight.

In our online pharmacy, super p‑force is available without a prescription, with discreet delivery to Australia in 5-14 days.

PBS Vs Private Cost Comparisons

PBS subsidies can substantially reduce cost for eligible patients purchasing individual agents such as generic sildenafil under specific criteria.

Fixed combination tablets are not PBS‑subsidised and private costs vary widely depending on source and shipping.

Rural consumers may face higher out‑of‑pocket costs and longer delivery times when ordering from overseas e‑pharmacies.

Comparison Of PBS And Non‑PBS Options

For erectile dysfunction covered under PBS criteria, generic sildenafil is an affordable option for eligible patients.

Dapoxetine remains prescription‑only and is not universally subsidised by the PBS, so private scripts are common.

Alternatives include tadalafil for longer action, vardenafil for faster onset, behavioural therapies for PE, and topical treatments to reduce sensitivity.

Pros And Cons Checklist

Pros of a fixed combination like Super P‑Force include single‑tablet convenience and standardised dosing for men with both ED and PE.

Cons include lack of TGA approval in Australia, reduced dosing flexibility, and potential supply quality concerns when imported.

Clinical Decision Points

Use separate agents when dose adjustment is likely, prioritise cardiometabolic assessment and consider psychosexual therapy as first‑line or adjunctive care.

TGA Approval Framework

The TGA assesses medicines for safety, quality and efficacy before granting local approval.

Sildenafil and dapoxetine are individually approved as prescription medicines in many jurisdictions but a fixed‑dose combination such as Super P‑Force is not recorded as TGA‑approved in Australia.

Health practitioners should always verify product registration before recommending imported combination tablets.

PBS Subsidy Process

PBS listing requires sponsor applications demonstrating clinical and cost‑effectiveness, and combination products generally face higher evidentiary hurdles.

There is currently no PBS subsidy for fixed sildenafil + dapoxetine combinations, so patients would pay private costs for the combo tablet.

Importation And Legal Considerations

Personal importation schemes allow limited patient imports but carry risks related to product quality and supply chain transparency.

Prescribers and pharmacists must follow TGA guidance when advising patients about unapproved medicines and document informed consent when applicable.

Consolidated FAQ

Q1: Is Super P‑Force legal in Australia?

A1: The fixed combination tablet is not TGA‑approved; sildenafil and dapoxetine individually are prescription medicines, and importation is possible but carries regulatory and safety caveats.

Q2: Can I take Super P‑Force with my heart meds?

A2: Not if you take nitrates, and many cardiac medicines need review by your GP or cardiologist before use.

Q3: Is it PBS‑subsidised?

A3: No, there is no PBS listing for the fixed tablet; separate agents may have PBS pathways if eligibility criteria are met.

Q4: What if I experience a prolonged erection or severe dizziness?

A4: Seek urgent medical attention; priapism (erection >4 hours) or syncope requires emergency care.

Q5: Are online imports safe?

A5: Safety varies — manufacturing oversight and labelling cannot be guaranteed for imports, so discuss purchases with your pharmacist.

Visual Guide

Infographics that are useful for practice and patient handouts include a PBS pricing flowchart that maps eligibility to likely out‑of‑pocket costs.

A pharmacy distribution map showing metro versus rural access, telehealth uptake and nearest chemist chains is practical for patient information.

A risk/benefit matrix that plots patient profile (age, cardiovascular risk, concurrent medicines) against suitability for a fixed combo versus separate agents aids prescribers.

Design notes for clinicians: use colour‑coded contraindication alerts (red for nitrates, orange for strong CYP inhibitors/SSRIs) and a quick counselling card with dosing window and emergency actions.

Use schematic tablet images labelled “Sildenafil 100 mg + Dapoxetine 60 mg” unless permission exists to use real packaging images.

Delivery Across Australia

Household Storage Under Australian Climate

Store tablets in their original blister pack and keep them below 30°C, out of direct sunlight and moisture, which is particularly important during hot, humid Australian summers.

Keep the medicine out of reach of children and discard any tablets that are past their expiry date or show obvious packaging damage.

Cold‑Chain Logistics For Pharmacies

Super P‑Force tablets do not require a strict cold chain but pharmacies should maintain ambient storage controls and avoid prolonged heat exposure in delivery vehicles during heat waves.

Pharmacies importing products should monitor supplier credentials and batch traceability to reduce the chance of compromised stock arriving in hot conditions.

Shipping And Import Notes

Patients ordering from online international suppliers may experience variable transit times and heat exposure in transit that can degrade active ingredients.

Pharmacists should advise customers to check packaging integrity, batch numbers and to return or report any suspicious products.

Pharmacist Counselling Style In Australia

Use a patient‑centred, evidence‑informed approach that begins by confirming the dual diagnosis of ED and PE and reviewing the complete medication list.

Assess cardiovascular risk, clarify dosing (one to three hours before sex, maximum one tablet per 24 hours), explain common side effects and outline emergency signs such as priapism or fainting.

Use private consultation rooms where available and document the counselling interaction with advice to follow up with the prescriber.

National Health Authority Recommendations

Follow TGA guidance on unapproved imported medicines and ensure adverse events are reported to support safety monitoring.

Prioritise safer prescribing where dose flexibility is required and encourage psychosocial and behavioural therapies alongside medication for sustainable outcomes.

Practical Scripts For Clinicians

“We can prescribe individual medicines to tailor dose; the fixed tablet exists but is unapproved here — let’s review your heart meds and consider the safest, evidence‑based option.”

Storage And Transport

• Store Below 30°C In Original Blister Packs And Avoid Direct Sunlight.
• Keep Out Of Reach Of Children And Do Not Use After Expiry.
• Pharmacies Should Avoid Prolonged Heat During Transit And Verify Supplier Credentials.

Guidelines For Proper Use

Confirm the diagnosis of erectile dysfunction and premature ejaculation before recommending combination therapy.

Perform medication reconciliation to identify nitrates, SSRIs or potent CYP inhibitors that could interact with sildenafil or dapoxetine.

Conduct cardiovascular risk assessment and consider specialist referral for patients with significant cardiac disease.

Advise the dosing window (one to three hours pre‑activity) and the maximum of one tablet per 24 hours.

Explain common side effects and the need for urgent care if an erection lasts longer than four hours or if severe dizziness occurs.

Document counselling and recommend follow‑up with the prescriber to review efficacy and tolerability.